Center for Coronary Heart Disease, Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Cardiovasc Diabetol. 2024 Sep 28;23(1):349. doi: 10.1186/s12933-024-02437-2.
To investigate the relationship between estimated glucose disposal rate (eGDR), a surrogate indicator of insulin resistance, and atherosclerotic cardiovascular diseases (ASCVD) incidence risk.
This prospective cohort study utilized data from the 6026 participants from the Multi-Ethnic Study of Atherosclerosis. The eGDR (mg/kg/min) was computed as 21.158 - (0.09 × waist circumference [cm]) - (3.407 × hypertension [yes/no]) - (0.551 × HbA1c [%]). The population was categorized into four subgroups according to the quartiles (Q) of eGDR. Cox proportional hazard models were applied to assess the associations between eGDR and ASCVD incidence, and restricted cubic spine (RCS) was employed to examine the dose-response relationship.
The mean age of participants was 63.6 ± 10.1 years, comprising 3163 (52.5%) women. Over a median follow-up duration of 14.1 years, 565 (9.4%) developed ASCVD, including 256 (4.2%) myocardial infarctions, 234 (3.9%) strokes, and 358 (5.9%) fatal coronary heart disease. Compared to the lowest quartile, the adjusted hazard ratios (95% confidence intervals) for incident ASCVD for Q2-Q4 were 0.87 (0.68-1.10), 0.63 (0.47-0.84), and 0.43 (0.30-0.64), respectively. Per 1 standard deviation increase in eGDR was associated with a 30% (HR: 0.70, 95% CI 0.60-0.80) risk reduction of ASCVD, with the subgroup analyses indicating that age and hypertension modified the association (P for interaction < 0.05). RCS analysis indicated a significant and linear relationship between eGDR and ASCVD incidence risk.
eGDR level was negatively associated with incident ASCVD risk in a linear fashion among the general population. Our findings may contribute to preventive measures by improving ASCVD risk assessment.
研究估计葡萄糖处置率(eGDR)与动脉粥样硬化性心血管疾病(ASCVD)发病风险之间的关系,eGDR 是胰岛素抵抗的替代指标。
本前瞻性队列研究利用了来自多民族动脉粥样硬化研究的 6026 名参与者的数据。eGDR(mg/kg/min)计算为 21.158-(0.09×腰围[cm])-(3.407×高血压[是/否])-(0.551×HbA1c [%])。根据 eGDR 的四分位(Q)将人群分为四组。应用 Cox 比例风险模型评估 eGDR 与 ASCVD 发病之间的关联,并用限制三次样条(RCS)检验剂量反应关系。
参与者的平均年龄为 63.6±10.1 岁,包括 3163 名(52.5%)女性。中位随访 14.1 年后,565 人(9.4%)发生 ASCVD,包括 256 例心肌梗死、234 例卒中和 358 例致命性冠心病。与最低四分位组相比,Q2-Q4 发生 ASCVD 的调整后风险比(95%置信区间)分别为 0.87(0.68-1.10)、0.63(0.47-0.84)和 0.43(0.30-0.64)。eGDR 每增加 1 个标准差,ASCVD 发病风险降低 30%(HR:0.70,95%CI:0.60-0.80),亚组分析表明年龄和高血压改变了这种关联(P 交互<0.05)。RCS 分析表明 eGDR 与 ASCVD 发病风险之间存在显著的线性关系。
在一般人群中,eGDR 水平与 ASCVD 发病风险呈负相关,呈线性关系。我们的发现可能通过改善 ASCVD 风险评估来促进预防措施。